SCHEMBL17627132

SCHEMBL17627132

C/C(=N/N=C(c1ccccc1)c1ccccc1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ PAX8 Q06710 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.47
▸ MAPT P10636 2/20 0.47
▸ PPARG P37231 1/20 0.44
▸ PPARA Q07869 1/20 0.44
▸ RAB9A P51151 2/20 0.42
▸ NR4A1 P22736 1/20 0.42
▸ NR4A2 P43354 1/20 0.42
▸ NR4A3 Q92570 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ GRIN2B Q13224 1/20 0.42
▸ KIF11 P52732 1/20 0.41
▸ CES2 O00748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17686769 1.00 CYP1A2 (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17686767 0.85 MAPT (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17627114 0.85 MAPT (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17686768 0.81 ALDH1A1 (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17627135 0.81 ALDH1A1 (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL28735779 0.77 ALDH1A1 (0.52) PAX8ALDH1A1MAPTRAB9ANR4A1
SCHEMBL14383620 0.76 PPARG (0.40) ALDH1A1PPARGPPARARAB9ANPC1
SCHEMBL13819189 0.76 HTR3E (0.47) CYP1A2CYP3A4CYP2C19ALDH1A1PPARG
SCHEMBL4279968 0.75 FURIN (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4037961 0.75 FURIN (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2999694-B1 PROCESS FOR PREPARING 3,5-BIS(FLUOROALKYL)PYRAZOLE DERIVATIVES FROM ALPHA,ALPHA -DIHALOAMINES BAYER CROPSCIENCE AG (DE) 2017-05-17 — — EP disclosed
US-9512081-B2 Process for preparing 3,5-bis(fluoroalkyl)pyrazole derivatives from α,α-dihaloamines BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-12-06 — — US disclosed
US-20160108000-A1 PROCESS FOR PREPARING 3,5-BIS(FLUOROALKYL)PYRAZOLE DERIVATIVES FROM a,a-DIHALOAMINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-04-21 — — US disclosed
EP-2999694-A1 PROCESS FOR PREPARING 3,5-BIS(FLUOROALKYL)PYRAZOLE DERIVATIVES FROM ALPHA,ALPHA -DIHALOAMINES Bayer CropScience Aktiengesellschaft (DE) 2016-03-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108000-A1 PROCESS FOR PREPARING 3,5-BIS(FLUOROALKYL)PYRAZOLE DERIVATIVES FROM a,a-DIHALOAMINES HDHD5, CYP4F3, AADAC CYP1A2 53/4885CYP3A4 20/4885CYP2D6 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback